Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update

2 years ago

The total operating revenues amounted to $7.9M and increased by 131% compared to H1 2022.Updated clinical and preclinical data on…

Mironid extends Series A round raising £35 million to date for development of first-in-class small molecules to treat life-threatening hereditary kidney disease

2 years ago

Roche Venture Fund joins existing major investors Epidarex Capital, Sofinnova Partners and BioGeneration VenturesSeptember 13, 2023: Glasgow, Scotland – Mironid,…

Novo Nordisk conducts a two-for-one stock split

2 years ago

Bagsværd, Denmark, 13 September 2023 – As communicated on 10 August 2023 in connection with the release of Novo Nordisk's…

DalCor Pharmaceuticals announces Dal-GenE-2 confirmatory trial and closing of Series D financing round

2 years ago

MONTREAL, Sept. 13, 2023 (GLOBE NEWSWIRE) -- DalCor Pharmaceuticals today announced the closing of the company’s Series D financing round…

Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

2 years ago

SAN DIEGO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the…

Ocugen to Host Virtual Investor & Analyst Event on September 13, 2023

2 years ago

Company to share updated results from ongoing Phase 1/2 trial of OCU400 for the treatment of Retinitis Pigmentosa and Leber…

Appeal launched to support Libya Floods Appeal

2 years ago

OTTAWA, Sept. 12, 2023 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the Libya Floods Appeal to help provide…

InnovAge Announces Financial Results For the Fourth Quarter and Fiscal Year Ended June 30, 2023

2 years ago

DENVER, Sept. 12, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), an industry leader in…

Dyadic to Present at BioProcess International

2 years ago

JUPITER, Fla., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology…

Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference

2 years ago

Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference Mont-Saint-Guibert, Belgium – September 12, 2023, 10:30pm CET / 4:30pm…